Key result
Repeated exposure to doxorubicin significantly reduced the utilization of pyruvate and acetate and inhibited the accumulation of formate in human induced pluripotent stem cell-derived cardiomyocytes.
Why the study?
Does doxorubicin exposure alter extracellular metabolite signatures in human induced pluripotent stem cell-derived cardiomyocytes?
Does doxorubicin exposure alter extracellular metabolite signatures in human induced pluripotent stem cell-derived cardiomyocytes?
p-value: p=<0.05
Pyruvate, acetate, and formate can serve as metabolite signatures for doxorubicin-induced cardiotoxicity in hiPSC-CM models, offering a novel approach for cardiac safety assessment in drug discovery.
Metabolic signatures may enable earlier cardiotoxicity detection in vitro; leaves open clinical translation and validation.
Drug-induced off-target cardiotoxicity, particularly following anti-cancer therapy, is a major concern in new drug discovery and development. To ensure patient safety and efficient pharmaceutical drug development, there is an urgent need to develop more predictive cell model systems and distinct toxicity signatures. In this study, we applied our previously proposed repeated exposure toxicity methodology and performed 1 H NMR spectroscopy-based extracellular metabolic profiling in culture medium of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exposed to doxorubicin (DOX), an anti-cancer agent. Single exposure to DOX did not show alteration in the basal level of extracellular metabolites while repeated exposure to DOX caused reduction in the utilization of pyruvate and acetate, and accumulation of formate compared to control culture medium. During drug washout, only pyruvate showed reversible effect and restored its utilization by hiPSC-CMs. On the other hand, formate and acetate showed irreversible effect in response to DOX exposure. DOX repeated exposure increased release of lactate dehydrogenase (LDH) in culture medium suggesting cytotoxicity events, while declined ATP levels in hiPSC-CMs. Our data suggests DOX perturbed mitochondrial metabolism in hiPSC-CMs. Pyruvate, acetate and formate can be used as metabolite signatures of DOX induced cardiotoxicity. Moreover, the hiPSC-CMs model system coupled with metabolomics technology offers a novel and powerful approach to strengthen cardiac safety assessment during new drug discovery and development.
No takes yet. Share an insight, caveat, or question.
Chaudhari et al. (2017) studied Doxorubicin-induced cardiotoxicity. Doxorubicin vs. DMSO solvent control was evaluated on Extracellular metabolite levels (pyruvate, acetate, formate) (p=<0.05). Repeated exposure to doxorubicin significantly reduced the utilization of pyruvate and acetate and inhibited the accumulation of formate in human induced pluripotent stem cell-derived cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: